High-sensitivity C-reactive protein: A useful marker for cardiovascular disease risk prediction and the metabolic syndrome

Clinical Chemistry

Volumn 51, Issue 3, 2005, Pages 504-505

  Rifai, Nader ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DATA ANALYSIS; DYSLIPIDEMIA; ETHNIC GROUP; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG FUNCTION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PRACTICE GUIDELINE; PREDICTION; PROGNOSIS; RISK FACTOR; SOCIAL STATUS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; METABOLIC SYNDROME X; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 14544294869     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.044990     Document Type: Note

References (8)

1. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004;109:2818-25.
2. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
3. Levinson SS, Miller JJ, Elin RJ. Poor predictive value of high-sensitivity C-reactive protein indicates need for reassessment. Clin Chem 2004;50:1733-5.
4. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65.
5. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
6. Ridker PM, Buring JE, Cook NR, Rifai N. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-7.
7. Foody JM, Gotto AM, Wenger N. C-Reactive protein and coronary heart disease. N Engl J Med 2004;351:295-8; author reply, 295-8.
8. Ridker PM, Koenig W, Fuster V. C-Reactive protein and coronary heart disease. N Engl J Med 2004;351:295-8; author reply, 295-8.